NovoCure Limited (NVCR) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

NVCR ranks #2806 out of 37503 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

NVCR is a top-conviction position for Soleus Capital Management, L.P. — at 5.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in NVCR belongs to FMR LLC, but the position matters far more to Soleus Capital Management, L.P., who has 5.2% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

California State Teachers Retirement System has added to its NVCR position for two straight quarters, increasing it by $115.8M to reach $117.1M today.

American Century Companies Inc has trimmed its NVCR position for two straight quarters, cutting it by $12.7M while still holding $795.0K.

NVCR is up 2.6% today, and institutions have been net buyers of $139.5M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

NVCR reported a net loss of $148.6M over the trailing twelve months.

• Not yet profitable — net loss of $148.6M over the trailing twelve months
• Revenue grew 11.0% year over year
• Net income improved year over year, from -$171.0M to -$148.6M
• Operating cash flow was negative, using $49.0M in cash
• Current ratio of 2.90x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.36x equity — within a conventional range